ArticleJCI insight2024

Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity.

Ofer Zimmerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.